[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 30, 1943

Blenorragia y sulfamidas. Blenorragia: Nociones generales de diagnóstico; tratamiento actual. Sulfamidas: Estudio clínico experimental. Sulfamidoterapia en la blenorragia

JAMA. 1943;121(5):379. doi:10.1001/jama.1943.02840050077034

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The subject matter consists chiefly of the diagnosis and modern treatment of gonorrhea, with clinical and experimental data. Of great interest are those sulfonamide compounds not generally used in the United States, such as uliron, neo-uliron, albucid and rodillone. With uliron Scherber and, independently, Löhe and his co-workers are quoted as claiming 75 per cent cures in 75 and 98 cases respectively. But the author obtained in 54 cases only 19 cures. In 11 per cent of these, prostatitis and epididymitis developed during treatment. With albucid the author quotes von Kennell as curing 86.5 per cent of 200 cases and St. Wolfran of Vienna as curing 98 per cent of 81 cases treated. The author himself, however, finds this drug less effective than sulfapyridine, even though better tolerated. Rodillone has been considered of value by Heitz-Boyer. Durel, however, obtained only 20 per cent cures and felt that the compound's greatest

First Page Preview View Large
First page PDF preview
First page PDF preview